Delivery Order SPE2DB22D3301-SPE2DB22FX7NQ
- Not listed
- This is a federal delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $26,704.20 firm-fixed-price contract is for the delivery of HERCEPTIN 150 MG VIALS, a medical supply. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563894398 HERCEPTIN 150 MG VIALS. The contract has a potential value of $10,602.36 and a completion date of March 28, 2024. Amerisourcebergen Drug Corp is the sole prime contractor on this delivery order, which is not associated with any set-aside designation. Additionally, Amerisourcebergen Drug Corp holds an...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 150 mg vials of the drug Herceptin, with a ceiling value of $26,704.20 and a performance period through July 25, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,681.68, is for the delivery of HERCEPTIN 150 MG VIALS. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,560.56 firm fixed-price contract is for the supply of HERCEPTIN 150 MG VIALS, with a performance period running through April 30, 2025. The contract is not designated as a set-aside and is open to full and open competition. Amerisourcebergen Drug Corp holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,583.08, is for the delivery of 4,568,175,562 units of the prescription drug Herceptin 150 mg vials. The contract is a firm fixed-price delivery order with a completion date of May 29, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HERCEPTIN 150 MG VIALS, a prescription medication, with a ceiling value of $21,363.36 and a completion date of July 22, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,670.42, is a Firm Fixed Price Delivery Order for the supply of HERCEPTIN 150 MG VIALS, a specialty pharmaceutical product. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Herceptin 150 mg vials, a specialty cancer medication, with a ceiling value of $28,484.48 and a period of performance through February 13, 2025. The contract is a firm fixed-price, delivery order type, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $10,669.36, is for the supply of HERCEPTIN HYLECTA 1S, a pharmaceutical product. The delivery order was issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB22FX7NQDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the provision of HERCEPTIN 150 MG VIALS. The contract, valued at $77,921.00, is a firm fixed-price delivery order without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $77.9k | 8/31/22 |